Gene editing in CHO cells to prevent proteolysis and enhance glycosylation: Production of HIV envelope proteins as vaccine immunogens.
Several candidate HIV subunit vaccines based on recombinant envelope (Env) glycoproteins have been advanced into human clinical trials. To facilitate biopharmaceutical production, it is necessary to produce these in CHO (Chinese Hamster Ovary) cells, the cellular substrate used for the manufacturing...
Main Authors: | Sophia W Li, Meredith Wright, John F Healey, Jennie M Hutchinson, Sara O'Rourke, Kathryn A Mesa, Pete Lollar, Phillip W Berman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0233866 |
Similar Items
-
CRISPR/Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation.
by: Gabriel Byrne, et al.
Published: (2018-08-01) -
Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine production.
by: Sara M O'Rourke, et al.
Published: (2018-01-01) -
Comparative immunogenicity of HIV-1 clade C envelope proteins for prime/boost studies.
by: Douglas H Smith, et al.
Published: (2010-08-01) -
Development of a Stable MGAT1− CHO Cell Line to Produce Clade C gp120 With Improved Binding to Broadly Neutralizing Antibodies
by: Rachel C. Doran, et al.
Published: (2018-10-01) -
Protein expression and glycosylation in CHO cells
by: Yuk, Inn Huam Yvonne.
Published: (2005)